Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma

Published:2022-01-03 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Kono Michihisa¹,Komatsuda Hiroki¹,Yamaki Hidekiyo¹,Kumai Takumi¹²^ORCID,Hayashi Ryusuke¹,Wakisaka Risa¹,Nagato Toshihiro³^ORCID,Ohkuri Takayuki³,Kosaka Akemi³,Ohara Kenzo¹,Kishibe Kan¹,Takahara Miki¹,Katada Akihiro¹,Hayashi Tatsuya¹²,Kobayashi Hiroya³,Harabuchi Yasuaki¹

Affiliation:

1. Department of Otolaryngology-Head & Neck Surgery, Asahikawa Medical University, Asahikawa, Japan

2. Department of Innovative Head & Neck Cancer Research and Treatment, Asahikawa Medical University, Asahikawa, Japan

3. Department of Pathology, Asahikawa Medical University, Asahikawa, Japan

Funder

JSPS KAKENHI

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.2021619